The FDA has given genomics firm Helix a wider emergency use authorization (EUA) for its pandemic test. The U.S. regulator said Helix is now allowed to offer its virus test for on-site and unsupervised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback